Advanced search
Publication Cover
OncoTargets and Therapy Volume 12, 2019 - Issue
Submit an article Journal homepage
47
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Clinicopathological Characteristics And EGFR-TKIs Efficacies In Lung Squamous Cell Carcinoma Patients Harboring An EGFR Sensitizing Mutation

Shaozhang Zhou1 Department of Respiratory Oncology, Guangxi Medical University Affiliated Tumor Hospital, Nanning 530021, People’s Republic of China
,
Huilin Wang1 Department of Respiratory Oncology, Guangxi Medical University Affiliated Tumor Hospital, Nanning 530021, People’s Republic of China
,
Wei Jiang1 Department of Respiratory Oncology, Guangxi Medical University Affiliated Tumor Hospital, Nanning 530021, People’s Republic of China
&
Qitao Yu1 Department of Respiratory Oncology, Guangxi Medical University Affiliated Tumor Hospital, Nanning 530021, People’s Republic of ChinaCorrespondence[email protected]
Pages 8863-8871 | Published online: 30 Oct 2019

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Danilo Rocco, Luigi Della Gravara, Ciro Battiloro, Paolo Maione & Cesare Gridelli. (2021) The treatment of advanced lung adenocarcinoma with activating EGFR mutations. Expert Opinion on Pharmacotherapy 22:18, pages 2475-2482.
Read now

Articles from other publishers (5)

Tian Gan, Wenting An, Yun Long, Jingting Wang, Hanfei Zhang & Meiyan Liao. (2023) Correlation between carcinoembryonic antigen (CEA) expression and EGFR mutations in non-small-cell lung cancer: a meta-analysis. Clinical and Translational Oncology.
Crossref
Xi Li, Wen-Bo Li, Qiang LuoYuan Liu. (2023) Efficacy of epidermal growth factor receptor tyrosine kinase inhibitor in the treatment of patients with nonsmall cell lung cancer. Medicine 102:38, pages e35081.
Crossref
Rui Jin, Ling Peng, Jiawei Shou, Jin Wang, Yin Jin, Fei Liang, Jing Zhao, Mengmeng Wu, Qin Li, Bin Zhang, Xiaoying Wu, Fen Lan, Lixia Xia, Junrong Yan, Yang Shao, Justin Stebbing, Huahao Shen, Wen Li & Yang Xia. (2021) EGFR-Mutated Squamous Cell Lung Cancer and Its Association With Outcomes. Frontiers in Oncology 11.
Crossref
Qing Chang, Huiping Qiang, Jialin Qian, Yuqiong Lei, Jiahuan Lu, Hui Feng, Yiming Zhao, Baohui Han, Yanwei Zhang & Tianqing Chu. (2021) Epidermal Growth Factor Receptor Mutation Status and Response to Tyrosine Kinase Inhibitors in Advanced Chinese Female Lung Squamous Cell Carcinoma: A Retrospective Study. Frontiers in Oncology 11.
Crossref
Linfang Wen, Shenghao Wang, Weiran Xu, Xiaofeng Xu, Mei Li, Yaqiong Zhang, Xiaobing Du & Shuang Liu. (2020) Value of serum tumor markers for predicting EGFR mutations in non-small cell lung cancer patients. Annals of Diagnostic Pathology 49, pages 151633.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.